Tuesday, October 21, 2025

Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics approval. The study is being conducted in connection with the development of iSTRYM, the firms digital therapeutics platform.

The ethics approval, which comes from Veritas IRB, effectively ensures that processes included in research studies respects participants rights and that they are delivered utilizing the highest standards of ethical practice in human studies. The approval effectively signifies the scientific validation of the study.

The study is being conducted to inform the development of iSTRYM, and how it is built out to best serve therapists, patients, and the psychedelics industry as a whole.

“As we build out iSTRYM to be the largest data repository of psychedelic experiences, we are ensuring that its development is rooted in research proof and a deep understanding of the systems and protocols provided during psychedelic therapy.”

Kelsey Ramsden, CEO of Mind Cure Health

Mind Cure Health last traded at $0.55 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Mind Cure Appoints Kelsey Ramsden As CEO And President

Mind Cure Health (CSE: MCUR) has shaken up its management team slightly, promoting COO Kelsey...

Tuesday, December 1, 2020, 08:51:06 AM

Mind Cure Announces Launch Of iSTRYM, A Mental Wellness Digital Therapeutics Tool

Mind Cure Health (CSE: MCUR) has launched a digital therapeutic tool which has been designed...

Wednesday, January 6, 2021, 07:26:11 AM

Mind Cure Appoints Dr Wolfram Tetzlaff To Advisory Board

It appears that Mind Cure Health (CSE: MCUR) is not quite yet done compiling its...

Tuesday, October 13, 2020, 09:01:47 AM

Mind Cure Announces New Product, Launch Dates For Nootropic Products

Mind Cure Health (CSE: MCUR) this morning announced that it intends to bring a new...

Tuesday, December 29, 2020, 07:14:06 AM

Mind Cure Health: A Glance At The Latest Additions To The Advisory Team

Over the course of the last two weeks, Mind Cure Health (CSE: MCUR) has slowly...

Sunday, October 11, 2020, 03:47:00 PM